Active ingredientPrazepamCat. No. P-P173-001CAS 2955-38-6Family · Pharmaceutical analytical standards
Prazepam
A benzodiazepine developed in the 1960s and used for the short-term treatment of anxiety; it also has sedative, anticonvulsant and muscle-relaxant properties. This family brings together the active ingredient, pharmacopoeial impurities and other impurities.
Did you know?It is a prodrug: almost all of its effect comes from nordazepam, the metabolite made by the liver, which stays in the body for a very long time, with a half-life of 36 to 200 hours.
Go to the active ingredient →Active ingredientPrazepamCat. No. P-P173-001CAS 2955-38-6
Pharmacopoeial impurityPrazepam EP Impurity BCat. No. P-P173-002CAS 2897-00-9
ImpurityNordazepamCat. No. P-P173-003CAS 1088-11-5No product matches your search.
EDQM standards 1
The official European Pharmacopoeia standards for this family.
Reference substancePrazepam CRSEDQM code P2669000Family PrazepamNeed a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.